Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8. doi: 10.1073/pnas.92.12.5694.

Abstract

A number of studies have suggested that topoisomerase I (topo I) activity may be important in human immunodeficiency virus type 1 (HIV-1) replication. Specifically it has been reported that purified virus particles have topo I activity and that inhibitors of this enzyme can inhibit virus replication in vitro. We have investigated a possible association of HIV-1 gag proteins with topo I activity. We found that whereas the gag-encoded proteins by themselves do not have activity, the nucleocapsid protein p15 can interact with and enhance the activity of cellular topo I. Furthermore it could be demonstrated that topo I markedly enhanced HIV-1 reverse transcriptase activity in vitro and that this could be inhibited by the topo I-specific inhibitor camptothecin. The findings suggest that cellular topo I plays an important role in the reverse transcription of HIV-1 RNA and that the recruitment of this enzyme may be an important step in virus replication.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • DNA Primers
  • DNA Topoisomerases, Type I / metabolism*
  • Gene Products, gag / physiology
  • HIV Reverse Transcriptase
  • HIV-1 / enzymology*
  • HIV-1 / genetics
  • HIV-1 / physiology
  • HeLa Cells
  • Humans
  • Molecular Sequence Data
  • RNA, Viral / genetics
  • RNA-Directed DNA Polymerase / metabolism*
  • Transcription, Genetic
  • Virus Replication

Substances

  • DNA Primers
  • Gene Products, gag
  • RNA, Viral
  • HIV Reverse Transcriptase
  • RNA-Directed DNA Polymerase
  • DNA Topoisomerases, Type I